TBIO
Translate Bio, Inc. Common Stock
TBIO
TBIO
Delisted
TBIO was delisted on the 13th of September, 2021.
132 hedge funds and large institutions have $936M invested in Translate Bio, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 61 increasing their positions, 27 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
57% less call options, than puts
Call options by funds: $2.12M | Put options by funds: $4.95M
Holders
132
Holding in Top 10
3
Calls
$2.12M
Puts
$4.95M
Top Buyers
| 1 | +$42.8M | |
| 2 | +$20.9M | |
| 3 | +$13.1M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$12.8M |
| 5 |
BlackRock
New York
|
+$8.36M |
Top Sellers
| 1 | -$19.2M | |
| 2 | -$18.1M | |
| 3 | -$17.9M | |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$17.9M |
| 5 |
LM
Luminus Management
Houston,
Texas
|
-$15M |